Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy

Zatz, Mayana, Rapaport, Debora, Vainzof, Mariz, Passos-Bueno, Maria Rita, Bortolini, Eliete R., Pavanello, Rita de Cassia M., Peres, Clovis A. · 1991 · Journal of the Neurological Sciences

Abstract

Serum creatine-kinase (CK) activities were determined in 536 patients affected with X-linked muscular dystrophy (456 with Duchenne or DMD and 80 with Becker or BMD) and serum pyruvate-kinase (PK) in 360 among them (309 DMD and 51 BMD). The aim of this investigation was to assess the variability and rate of decrease in serum activity in DMD as compared with BMD as a function of age and in DMD as a function of Vignos scale as well. In DMD, maximum CK and PK activities were found around 1-6 years old and the average rate of decline according to age was estimated as 0.18 per year and 0.27-0.29 for both enzymes as a function of Vignos scale (assessed in 291 cases). For BMD, maximum serum enzyme levels were found around 10-15 years old and the rate of decline of serum activity per year was 0.06 for CK and 0.07 for PK. If maximum levels of serum enzyme reflect active muscle degeneration and the rate of decline per year to progressive loss of muscle mass (responsible for the release of muscle enzymes to the blood stream) our observations suggest: (a) active muscle degeneration occurs, on average, 5 years later in the group of outliers and 10 years later in BMD as compared with severe DMD; (b) the rate in which muscle mass is lost is significantly greater in DMD than in BMD and therefore serum enzyme determinations may represent an important test for evaluation of therapeutic trials; (c) serum enzymes determination may represent an important preliminary test to discriminate in a proportion of young patients if they will develop a severe or milder phenotype.

Overview

Integrity signals

Registry

Crossref · 10.1016/0022-510x(91)90068-i

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Wu, 1988, Evidence for abnormal growth hormone (GH) in a boy with Duchenne muscular dystrophy (DMD) and growth failure, Pediatr. Res., 23, 560A

Cited by

See all 159

Metadata

Authors
Zatz, M., Rapaport, D., Vainzof, M., Passos-Bueno, M. R., Bortolini, E. R., Pavanello, R. D. C. M., & Peres, C. A.
Affiliations
  • Universidade de São Paulo (BR)
  • Universidade Federal do Espírito Santo (BR)
Corresponding author
Zatz, Mayana
Venue
Journal of the Neurological Sciences
Publisher
Elsevier BV
Published
1991-04
Volume
102
Issue
2
Pages
190-196
ISSN
0022-510X (ISSN-L)
OpenAlex
W2045209184
Cited by
159
References
35
Citations by year
2026: 3 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 12 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 8 · 2015: 17 · 2014: 12 · 2013: 4 · 2012: 2
FWCI
1.19
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Journal of the Neurological Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
Keywords
Duchenne muscular dystrophy, Becker muscular dystrophy, serum creatine kinase, X-linked muscular dystrophy, muscle degeneration, muscle mass loss, age-related enzyme decline
MeSH terms
Adolescent, Adult, Age Factors, Child, Child, Preschool, Creatine Kinase, Humans, Infant, Muscular Dystrophies, Predictive Value of Tests, Pyruvate Kinase, Regression Analysis, Severity of Illness Index, Dystrophin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. https://app.cochat.ai/papers/10.1016/0022-510x(91)90068-i
The paper
Zatz, M., Rapaport, D., Vainzof, M., Passos-Bueno, M. R., Bortolini, E. R., Pavanello, R. D. C. M., & Peres, C. A. (1991). Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. Journal of the Neurological Sciences. https://doi.org/10.1016/0022-510x(91)90068-i

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.